New evidence layer and UK acquisition expand Heidi’s role across the clinical workflow
MELBOURNE, Australia - February 24, 2026 - Heidi, the leading healthcare AI platform, today announced major milestones in its mission to redefine how healthcare is delivered: the launch of Heidi Evidence and the acquisition of UK-based clinical AI pioneer AutoMedica. This comes alongside the launch of Heidi Comms, an AI partner for healthcare teams to coordinate patient communications across calls, bookings, reminders and follow-ups.
These moves mark Heidi’s evolution from an AI scribe into a comprehensive AI Care Partner, bridging the gap between clinical documentation and real-time clinical reasoning. Clinical evidence underpins everyday decisions in patient care, from confirming diagnoses and selecting treatments to determining dosages, follow-up plans, and safety considerations.
"We believe that for AI to be a true care partner, the integrity of its evidence must be non-negotiable," said Dr. Thomas Kelly, Co-Founder and CEO of Heidi. "As we see more general-purpose AI platforms like OpenAI move toward ad-supported models, consumers are rightly concerned about hidden influence.
In a healthcare setting, that concern becomes paramount. Bringing transparent, clinical-grade insights into the room makes it easier to deliver quality care, but that information must be free from the ambiguity of commercial influence. By committing to Evidence being ad-free and independent, we ensure clinicians can stay present with their patients, knowing their decision-making is built on pure clinical rigor, not a business model."
